Synta Pharma CEO Trumpets New Top Cancer Drug
Linkedin

Synta Pharma CEO Trumpets New Top Cancer Drug

Salt Lake City : UT : USA | Jul 12, 2010 at 7:59 AM PDT
Source: The Motley Fool
XX XX
Views: Pending
 

Boston area's highest-profile clinical trial failures of 2009 . And a big part of the Lexington, MA-based company's recovery has been to learn from the failure and advance other drug candidates in its pipeline. After Synta halted its pivotal trial of the drug elesclomol for patients with a deadly form of skin cancer in February 2009, the firm saw its common stock value fall more than 80 percent in a day.

FULL ARTICLE AT The Motley Fool
 
  • Clear
  • Share:
  • Share
  • Clear
  • Clear
  • Clear
  • Clear
 
 
Advertisement
 
Advertisement
 

More From Allvoices

Related People

 
Tap_logo_330_110_event
 


Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

© Allvoices, Inc 2008-2013. All rights reserved.